Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
J Agric Food Chem ; 72(33): 18561-18572, 2024 Aug 21.
Article in English | MEDLINE | ID: mdl-39121367

ABSTRACT

Orthosiphon stamineus Benth. (OSB) is a popular plant used for making "Shen tea" or "Java tea". It has been demonstrated with antioxidant, anti-inflammatory, and hepatoprotective activities. However, its potential beneficial effects and bioactive material basis for nonalcoholic fatty liver disease (NAFLD) has not been convincingly studied. In the present work, we conducted dual phytochemical/activity-guided extraction optimization and component fractionation of OSB, and evaluated its beneficial effects on NAFLD. Flavonoids and polyphenols (caffeic acid/protocatechuic acid derivatives) were determined as the dominant phytochemicals in OSB. The extraction process for these phytochemicals was optimized by using response surface methodology. Noticeably, flavonoids showed a stronger correlation with the antioxidant activities of OSB than polyphenols. Likewise, the flavonoid-rich fraction of OSB exerted antioxidant activities stronger than those of other fractions. As expected, in vitro and in vivo studies demonstrated that the flavonoid-rich fraction effectively attenuated weight increase, improved lipid metabolism, alleviated hepatic steatosis, and reversed hepatic inflammation. Importantly, this fraction showed equivalent beneficial effects to the total extract of OSB, suggesting that flavonoids were the main bioactive constituents of OSB. The action mechanism was indicated as direct antioxidant effect through chemical interaction with free radicals and indirect mitochondria-mediated antioxidant defense. Our research offers bioactive substances for further exploitation and expands the potential application of OSB.


Subject(s)
Flavonoids , Non-alcoholic Fatty Liver Disease , Orthosiphon , Plant Extracts , Non-alcoholic Fatty Liver Disease/drug therapy , Non-alcoholic Fatty Liver Disease/metabolism , Orthosiphon/chemistry , Animals , Male , Plant Extracts/chemistry , Plant Extracts/pharmacology , Flavonoids/chemistry , Humans , Mice , Antioxidants/chemistry , Antioxidants/pharmacology , Phytochemicals/chemistry , Phytochemicals/pharmacology , Polyphenols/chemistry , Polyphenols/pharmacology , Liver/drug effects , Liver/metabolism , Mice, Inbred C57BL , Lipid Metabolism/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL